Microfluidics, Bioengineering, Biotechnology, Pharmaceutical, Innovation.
µVS devices and protocols result in optimal yield or the percentage of recovered, viable and modified T cells. In more detail, a numerical study of detailed wake patterns of laminar flow past microarrays platform is briefly presented here. Our standard µVS device geometry for activated T cells is